ATG5 and Parkinson disease: And microglia-specific knockdown of ATG5 aggravated motor dysfunction and dopaminergic neurodegeneration, enhanced microgliosis and astrogliosis, exacerbated NLRP3 inflammasome activation in the substantia nigra (SN) of MPTP-induced PD mice [27].